These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 19106147

  • 1. JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand.
    Mucha SR, Rizzani A, Gerbes AL, Camaj P, Thasler WE, Bruns CJ, Eichhorst ST, Gallmeier E, Kolligs FT, Göke B, De Toni EN.
    Gut; 2009 May; 58(5):688-98. PubMed ID: 19106147
    [Abstract] [Full Text] [Related]

  • 2. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H.
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [Abstract] [Full Text] [Related]

  • 3. CAPE promotes TRAIL-induced apoptosis through the upregulation of TRAIL receptors via activation of p38 and suppression of JNK in SK-Hep1 hepatocellular carcinoma cells.
    Kim EY, Ryu JH, Kim AK.
    Int J Oncol; 2013 Oct; 43(4):1291-300. PubMed ID: 23857473
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest.
    Kuntzen C, Sonuc N, De Toni EN, Opelz C, Mucha SR, Gerbes AL, Eichhorst ST.
    Cancer Res; 2005 Aug 01; 65(15):6780-8. PubMed ID: 16061660
    [Abstract] [Full Text] [Related]

  • 5. 1-Methoxy-canthin-6-one induces c-Jun NH2-terminal kinase-dependent apoptosis and synergizes with tumor necrosis factor-related apoptosis-inducing ligand activity in human neoplastic cells of hematopoietic or endodermal origin.
    Ammirante M, Di Giacomo R, De Martino L, Rosati A, Festa M, Gentilella A, Pascale MC, Belisario MA, Leone A, Turco MC, De Feo V.
    Cancer Res; 2006 Apr 15; 66(8):4385-93. PubMed ID: 16618764
    [Abstract] [Full Text] [Related]

  • 6. Cordycepin increases sensitivity of Hep3B human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by inactivating the JNK signaling pathway.
    Lee HH, Jeong JW, Lee JH, Kim GY, Cheong J, Jeong YK, Yoo YH, Choi YH.
    Oncol Rep; 2013 Sep 15; 30(3):1257-64. PubMed ID: 23828231
    [Abstract] [Full Text] [Related]

  • 7. [Study on effect and mechanism of Honokiol enhancing tumor necrosis factor-related apoptosis inducing ligand against hepatocellular carcinoma HepG2 cells via activating JNK signaling pathway].
    Xiao G, Yang R, Dang L, Dong CL.
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun 20; 26(6):441-445. PubMed ID: 30317758
    [Abstract] [Full Text] [Related]

  • 8. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I.
    Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619
    [Abstract] [Full Text] [Related]

  • 9. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma.
    Shiraki K, Yamanaka T, Inoue H, Kawakita T, Enokimura N, Okano H, Sugimoto K, Murata K, Nakano T.
    Int J Oncol; 2005 May 01; 26(5):1273-81. PubMed ID: 15809718
    [Abstract] [Full Text] [Related]

  • 10. Novel TRAIL sensitizer Taraxacum officinale F.H. Wigg enhances TRAIL-induced apoptosis in Huh7 cells.
    Yoon JY, Cho HS, Lee JJ, Lee HJ, Jun SY, Lee JH, Song HH, Choi S, Saloura V, Park CG, Kim CH, Kim NS.
    Mol Carcinog; 2016 Apr 01; 55(4):387-96. PubMed ID: 25647515
    [Abstract] [Full Text] [Related]

  • 11. Ribotoxic stress sensitizes glioblastoma cells to death receptor induced apoptosis: requirements for c-Jun NH2-terminal kinase and Bim.
    Xia S, Li Y, Rosen EM, Laterra J.
    Mol Cancer Res; 2007 Aug 01; 5(8):783-92. PubMed ID: 17699104
    [Abstract] [Full Text] [Related]

  • 12. Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins.
    Park MH, Jo M, Won D, Song HS, Song MJ, Hong JT.
    Apoptosis; 2012 Dec 01; 17(12):1316-26. PubMed ID: 23007278
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of MKK7-JNK by the TOR signaling pathway regulator-like protein contributes to resistance of HCC cells to TRAIL-induced apoptosis.
    Song IS, Jun SY, Na HJ, Kim HT, Jung SY, Ha GH, Park YH, Long LZ, Yu DY, Kim JM, Kim JH, Ko JH, Kim CH, Kim NS.
    Gastroenterology; 2012 Nov 01; 143(5):1341-1351. PubMed ID: 22841785
    [Abstract] [Full Text] [Related]

  • 14. Essential role of c-Jun-NH2-terminal kinase on synergy induction of apoptosis by TRAIL plus ADM in ADM resistant MCF-7/ADM cells.
    Li F, Meng L, Xing H, Zhou J, Wang S, Huang L, Xu G, Zhu H, Lu Y, Ma D.
    Apoptosis; 2006 Jul 01; 11(7):1239-46. PubMed ID: 16703262
    [Abstract] [Full Text] [Related]

  • 15. Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity.
    Malhi H, Barreyro FJ, Isomoto H, Bronk SF, Gores GJ.
    Gut; 2007 Aug 01; 56(8):1124-31. PubMed ID: 17470478
    [Abstract] [Full Text] [Related]

  • 16. Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.
    Nakshatri H, Rice SE, Bhat-Nakshatri P.
    Oncogene; 2004 Sep 23; 23(44):7330-44. PubMed ID: 15286701
    [Abstract] [Full Text] [Related]

  • 17. c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells.
    Vivo C, Liu W, Broaddus VC.
    J Biol Chem; 2003 Jul 11; 278(28):25461-7. PubMed ID: 12707267
    [Abstract] [Full Text] [Related]

  • 18. A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells.
    Park KJ, Lee SH, Kim TI, Lee HW, Lee CH, Kim EH, Jang JY, Choi KS, Kwon MH, Kim YS.
    Cancer Res; 2007 Aug 01; 67(15):7327-34. PubMed ID: 17671202
    [Abstract] [Full Text] [Related]

  • 19. TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality.
    Corazza N, Jakob S, Schaer C, Frese S, Keogh A, Stroka D, Kassahn D, Torgler R, Mueller C, Schneider P, Brunner T.
    J Clin Invest; 2006 Sep 01; 116(9):2493-9. PubMed ID: 16955144
    [Abstract] [Full Text] [Related]

  • 20. JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells.
    Recio-Boiles A, Ilmer M, Rhea PR, Kettlun C, Heinemann ML, Ruetering J, Vykoukal J, Alt E.
    Oncotarget; 2016 Mar 01; 7(9):9890-906. PubMed ID: 26840266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.